Approval · Notice of Compliance 17741 · 2016
TILDREN: Notice of Compliance 17741
Issued February 3, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17741
- Date
- February 3, 2016
- Company
- Ceva Animal Health IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Therapeutic class
- Biophosphonate
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TILDREN | 02435705 | Approved |
Medicinal ingredients
- TILUDRONATE DISODIUM 500 MG per VIAL